In this relation, particularly in brain tumors, where vascular endothelial growth factor (VEGF) and its receptor VEGFR2 are overexpressed, immunoliposomes can offer a targeted approach to combat angiogenesis and metastasis [54]. This evidence concerns the gene VEGFA and brain neoplasm.